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We investigated malaria, typhoid and HIV co-infections among 600 persons in Uzo-Uwani Local 
Government Area of Enugu State, Southeast Nigeria and the effect of some herbal concoctions 
administered in the locality on the CD4 counts of those infected with malaria, typhoid and HIV. Of 600 
patients screened, 286 (47%), were infected with HIV, 452 (75%) with malaria, and 401 (66%) with typhoid).  
Only 54 (9%) was uninfected. HIV infection was higher in those aged 26-35 years followed by those 
between 36-45 years. The prevalence of malaria was higher in males compared to females. The reverse 
was the case for typhoid although these gender differences were not statistically significant (p > 0.05). Of 
the 600 screened, 546 persons had malaria, typhoid and HIV co-infection.  The greatest number (121) of 
these triply co-infected persons had CD4 counts that ranged from 201-300 cells/µl. Average counts of 
other hematologic parameters were: 514+21 for CD4 cell count; 15.01 ± 4.1 for WBC; 84.56 ± 81 for 
lymphocyte count, and 69.18± 3.0 for red blood cell (PCV). On the gender level, out of the 546 triply 
infected persons observed, 232 were males, and 314, females, with preponderance of female to male 
ratios. The effect of conventional antiretroviral therapy (ART), and herbal concoction separately on the 
CD4 counts of the 50 triply infected volunteers (with baseline CD4 counts below 200cells/µl) were 
evaluated in one monthly intervals of treatment. Prior to this treatment, the 50 volunteer patients had 
mean CD4 count of 118.60+60.17 cells/µl. Following administration of the antiretroviral and the herbal 
concoctions, a total of 39 patients responded positively to the treatment, with significantly increased 
mean CD4 count of 202.31+86.72 cells/µl. Using the different antiretroviral drugs and effectors, it was 
observed that the different drug regimen significantly boosted  the CD4 count at the end of treatment (p < 
0.05). No significant difference (p > 0.05) was found in the CD4 cell count of male and female volunteers 
before (110.25 +55.51 vs. 122.78 +62.81 cells/µl) and after (177.69+82.64 vs. 214.63+87.34 cells/µl) 
treatment. Similarly, levels of TWBC, HB and PCV were significantly improved (p < 0.05) following the 
treatment. Furthermore, when the TWBC, HB and PCV of volunteers who had negative and positive 
response after treatment were compared, only the HB of those who responded positively to treatment 
showed a significant increase (p < 0.05). 
 





Malaria remains Africa's leading cause of under-five 
mortality (20%), and constitutes 10% of the 
continent's overall disease burden. Malaria infection 
in Nigeria is caused by Plasmodium falciparum, the 
most severe and life-threatening form of the 
disease. Typhoid fevers which include both typhoid 
and paratyphoid fevers are multi-systemic diseases 
with fluctuating clinical presentations including 
primary gastrointestinal lesions. Salmonella typhi is 
the dominant stereotype in Nigeria, with percentage 
incidence of 60-68% (Bello and Tanyigna, 1996). 
Though with distinct aetiology and transmission 
modes, malaria and typhoid share some similarities; 
one mimicking the other in their presenting clinical 
signs and symptoms especially in the early stages 
of the disease; and syndromes produced by both 
diseases often present with diagnostic difficulties 
and confusions.   
Co-infection with malaria and intestinal 
parasites are indicated to exacerbate the outcome 
of HIV infection by polarizing the immune response 
towards Th2.  HIV infection is interrupts the 
acquired immune response to malaria; the risk of 
parasitemia, high parasite density and malaria fever 
increase viral local of HIV patients. Plasmodium 
falciparum has been shown to stimulate HIV 
replication through the production of cytokines 
(including interleukin 6 and tumor necrosing factor a 
(FNfa) by activated lymphocytes, thereby increasing 
the incidence and severity of malaria; and therefore 
causing an upsurge in the risk of HIV transmission 
(Froebel et al., 2004). These interactions therefore 
pose a serious public health threat especially in the 
malarious and heavily HIV-infected populations of 
Nigeria, thus calling for the strengthening of 
preventive measures in these locations. Until now, 
the world has relied on plants for the best malaria 
drugs: chloroquine from Cinchona tree; and 
Artemisinin from Chinese salad plant, 
Artemisuaannua. Following the devastating effect of 
HIV infection, there is the daily upsurge in P. 
falciparum resistance to the World Health 
Organisation (WHO) celebrated drug, Artemisin 
combination. Nigerian folkloric medicine employs 
the use of Cleistopholis patens (Benth), Terminalia 
avicennioides, Momordicabalsamina, 
Combretuimpaniculatum and Tremaguineensi 
against multi-drug resistant parasitic pathogens 
especially S. typhi (MDR) strains (Dalziel, 1937). 
This study investigated the effect of  herbal 






concoctions on CD4 cell counts and other 
haematological indices (surrogate markers) of HIV 
disease progression among people living with 
HIV/AIDS in the area of study. 
 
Materials and Methods 
 
HIV screening: A 5-ml blood sample was collected 
with blood collection tubes (Vacutainer CPT; Becton 
Dickinson, Basel, Switzerland). Plasma was 
separated within 2 hours and either processed 
immediately or frozen at −80°C until use.  Samples 
were screened for HIV antibodies using the Genie 
HIV-1/2 kit (Sanofi Diagnostics Pasteur, Montreal, 
Quebec), a synthetic- peptide solid-phase enzyme 
immunoassay according to Manufacturer‟s 
instructions. The lower limit of detection of this 
assay was 400 copies per milliliter.  Positive results 
were confirmed using the „Determine‟ and „Stat-pak‟ 
kits manufactured by Abbot and Chembio 
Laboratories respectively.  
 
Malaria parasite estimation using giemsa stain: 
Five (5) ml blood sample was collected from each 
patient by venipuncture for malaria parasite assay. 
Duplicate thin and thick blood films were prepared 
immediately following blood collection on separate 
slides. A small volume of blood (3.0-4.0µl) was 
used for the preparation of a thick film on a grease-
free glass slide. Thick smear of the blood was made 
by gentle mixing for 20-30 seconds using a slide 
spreader to de-fibrinate the blood and to obtain a 
round smear of about 1cm in diameter. The film was 
allowed to air-dry at a horizontal position. Thin film 
was then made by spreading  2 µl of blood from the 
edge of a glass slide with  a swift sweep using  a 
thin glass slide.  The films were then fixed in 
absolute methanol for 1-2 sec and air dried.  Each 
slide was then labeled with appropriate code. A 
10% solution of 3% Giemsa  stain ( pH 7.). was 
diluted by dispensing  5mls of the stain to 45ml  
normal saline. Slides were placed on a staining rack 
and to each was poured 5mls of the diluted Giemsa. 
Contact was maintained for 10 minutes, after which 
stain was washed off with water, and the slides  
allowed to drain before  air-drying in a vertical 
position away from dust and possible contaminant.  
All the blood films were stained after 24-48 hr. The 
slides were then observed under a 100x objective 
magnification. The WHO approved method for 
parasite enumeration was adopted( WHO,1985). 
Quality control was maintained using standard 
positive and negative films as well as standard 
operation procedures.  
 
Malaria Parasite Determination:  
Dipstick antigen-capture assays for P. 
falciparum histidine-rich protein: The test device 
is a rapid chromatographic immunoassay for the 
qualitative detection of circulating Plasmodium 
falciparum in whole blood. The test utilizes colloid 
gold conjugate to selectively detect P. falciparum 
antigen in whole blood. The membrane is pre-
coated with P. falciparum antibody. During testing, 
the whole blood specimen reacts with the dye 
conjugate, which has been pre-coated on the test 
strip. Through capillary action the mixture migrates 
upward on the membrane and reacts with Pf 
antibody on the test line. The Dipstick, an antigen 
capture assay is based on immunological detection 
of P. falciparum histidine-rich protein. The 
procedure takes a total of 15–20 minutes, and the 
results are read visually and interpreted depending 
on the presence or absence of colored stripes on 
the dipstick. The test device was obtained from the 
foil pouch and placed on a leveled surface. A micro 
pipette was used to obtain some blood (10µl) from 
the EDTA bottle and applied to the specimen well of 
the test device. Two drops of the buffer solution was 
also added to the specimen well to disrupt the red 
blood cells, release the antigens and enhance 
capillary movement of the blood through the test 
cassette. After 15 minutes, the devices were 
examined for presence of coloured bands. The 
results of each assay were recorded as positive or 
negative on the basis of the observation of the 
precipitated band. Two distinct coloured bands were 
confirmatory for the presence of malaria parasite. 
 
Screening for S. typhi Using Widal Test:  
Qualitative slide agglutination test: The rapid 
agglutination test by slide titration method using 
commercial antigen suspension (cal - Test 
Diagnostic inc. Chino, U.S.A) for somatic (O) and 
flagella (H) antigens was adopted for the Widal test. 
One drop (0.5 ml) each of undiluted patient serum 
samples for the four antigens was  placed on each 
circled card and one drop of each of the four 
Salmonella antigens were added separately, and 
gently rotated for one minute. Positive and negative 
controls were also maintained.  Appearance of 
agglutination gave qualitative results. The titre for 
each of the antigens, was determined by a repeat 
test with dilutions of serum. This was carefully 
carried out for precision. 
 
Quantitative slide agglutination test: 
Approximately 80 μl, 40 μl, 20 μl, 10 μl and 5 μl of 
patient‟s serum each for the four antigens were 
dispensed on the circled card. To each series of 
serum specimen, was added one drop of specific 
antigen, mixed and rotated for one minute. 
Agglutination in each of these was then observed:  
80 μl corresponded to 1 in 20 dilution, 40 μl to 1 in 
40, 20 μl to 1 in 80, 10 μl to 1 in 160 and 5 μl 
corresponds to 1 in 320 titre.  Serum samples with a 
titre of 1:160 for S. typhi antigens were considered 
positive results. 
 
Quantitative Tube Agglutination Test 
Procedure for tube agglutination test: 
Approximately 0.5ml of patient serum in sterile test 
tubes was doubly diluted by mixing and transferring 
from 1:10 to 1:640 in three-five rows. To the tubes 
in the first row was added somatic S. typhi O 
antigen, while to all the remaining rows, were added 
different flagella H antigens. A test tube with only 
saline was kept in each row as control. All the tubes 
(including control) in a row were mixed with 0.5ml of 
antigen suspension. The first row was treated with 
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S. typhi O antigen, the second row with S. typhi H 
antigen, the third row with S. paratyphi AH antigen. 
The fourth row with S. paratyphi BH antigen, and 
the fifth row with S. paratyphi CH.  Following 
addition of the antigens, the tubes contained in a 
rack were placed in a thermostatically controlled 
water bath maintained at 37
o
C for overnight 
incubation, after which the tubes were examined for 
agglutination, using the control tubes with no 
agglutination as reference point.  Agglutination test 
of O antigen appeared as a “matt” or “carpet” at the 
bottom of each tube; while that of H antigens 
maintained  loose, wooly or cottony appearance. 
The highest dilution of serum that produced a 
positive agglutination was taken as the titre. 
 
Other Haematological Parameters: 
CD4 cell count: HIV positive samples were 
assayed for CD4 by the Cyflow technique using the 
Cyflow counters (Partec), for both counting and 
analyses of particles and cells.  Blood samples 
were stained with fluorescent dye, and allowed to 
stand for about 5 mins for the dye molecules to be 
imbibed by the cells (this was illuminated at defined 
wavelength). The color intensity for each labeled 
cell was measured by a ploidy analyzer; the 
intensity of emitted light was proportional to its CD4. 
The concentration or volume of fluorescent cell was 
measured at 0.2 ml by the volume detector, while 
the ploidy analyzer determined the number of cells 
per ml. CD4 cell counts were monitored at 6 month 
intervals. Overall treatment efficacy was defined as 
an increase of the CD4 cell count by at least 50% of 
the baseline value, while AIDS was defined as 
clinical stage C of the 1993 classification system 
(CDC, 1993). 
 
Haematological tests: An automated Coulter 
counter T540 machine, standardized against a 4C 
plus blood control was used for haematological 
parameter estimation. The machine automatically 
diluted 29.6 µl whole blood samples, lysed, counted 
and printed out the result of absolute numbers of 
White Blood Cells, Red Blood Cells and 
lymphocyte.   
 
Antiretroviral therapy (ART): Within the context of 
this study, the highly active antiretroviral therapy 
(HAART) a combination therapy which targets 
multiple steps in HIV replication: triple combination 
treatment with 2 RTIs and 1 protease inhibitor; or 1 
RTI and 2 protease inhibitors  was used following 
the WHO recommended  guideline as follows:  
 Zidovudine (AZT): 300 mg twice daily 
 Lamivudine (3TC): 150 mg twice daily 
 Nevirapine (NVP):  200 mg twice daily for 
first 14 days,    
 Efavirenz (EFV): 600 mg   once daily (at 
bedtime) 
Stavudine (D4T): 40 mg every 12 hours for adults 
of > 60kg body weight  and 30mg every 12 
hours  for adults < 60kg body weight 
Didanosine (DdI): 400 mg once daily for adults > 
60kg body weight  and 250mg daily for adults < 
60kg body weight. 
Time was measured from the date of starting 
treatment to the date of the last follow-up visit (June 
2, 2009 to June 30, 2010). Patients were 
maintained in the original regimen for the period of 
study following initial trial regimen to determine level 
of tolerance according to body weight. Compliance 
and/or adherence was maintained by close 
monitoring and advise. Exclusion criterion included 
pregnant women as a result of difference in their 
HAART regimen requiring that women not already 
taking treatment, but requiring HAART, should defer 
commencement until second trimester after the 
period of organogenesis and when symptoms of 
morning sickness are likely to have settled.  
Gestational period was not determined among the 
pregnant women, hence their illegibility for the 
study. CD4 cell counts were monitored at 6 monthly 
intervals. 
 
Herbal treatment for typhoid and malaria: 
Treatment cocktail for malaria and typhoid was 
carried out using several local medicinal herbs 
commonly used in folkloric medicine for the dual 
treatment of malaria and typhoid infections,  
namely; 
1. Alstonei boonei 
2.   P. nitida  
3. Cleistropholis patens (Benth) 
4. Occimum gratissimum 
 
Herbal preparation and administration: Fresh 
leaves of the plants were collected from around the 
local communities of Nsukka and authenticated by a 
professional taxonomist, Mr A. Ozioko at the 
Department of Botany, University of Nigeria, 
Nsukka. Leaves were mixed in equal proportions 
and thoroughly washed in clean water and boiled 
for 20-30 min until leaves turned brown.  The 
concoction was then drained into large clean pot 
and allowed to cool, after which it was dispensed 
into bottles and preserved by refrigeration.   A glass 
(25cl) of the concoction was administered to each 
volunteer patient twice daily for two weeks.  Fresh 
preparations were however made weekly to ensure 
sterility and viability of content, avoid contamination 
and degradation of product following overstay. 
 
Prophylaxis, Using Moringa oleifera Leaves and 
Seed: 
Moringa Processing: Moringa leaves and seeds, 
with their rich sources of  macro and micro- 
nutrients: Vitamins A and  C, Calcium, protein and 
potassium were also incorporated into the cocktail 
for  energy boosting  and immune restoration as 
well as system detoxification.  Fresh leaves of 
Moringa oleifera were collected from Ifite-Ogwari in 
Ayamelum Local Government Area of Anambra 
State. Leaves were thoroughly washed and drained 
in a clean local basket (Nkata or Ekete in Igbo), and 
then allowed to dry  indoors for about 2 weeks with 
regular turning to avoid decay and mold 
contamination and to ensure even drying. Dry 
leaves were then pulverized using electric blender 
(Model -).  Ground leaves were further dried in a 
microwave for 5 mins to ensure proper drying, and 
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allowed to cool before packaging in dry air-tight 
plastic containers. Mature Moringa oleifera seeds 
were carefully removed from pods, and stored in 
tight plastic containers without removing the husk to 
avoid contamination with mold.   
 
Administration of Moringa tea: Each volunteer 
patient was given a cup of Moringa tea, consisting 
of 1 tablespoon of dry Moringa leaves mixed in 
warm water before meal twice daily for 2 weeks at 1 
week interval  following the herbal treatment for 
malaria and typhoid fevers.  Subsequently, 3 seeds 
of Moringa were given to each patient to chew 
nightly before going to bed. 
 
Ethical consideration: The ethical consent of the 
Community leaders of the study population as well 
as the consenting volunteers was obtained prior to 
commencement of this study. Oral discussion on 
the nature and efficacy of the project was carried 
out before administration of questionnaires and 
commencement of and laboratory studies.  Due to 
the social stigmatization and rejection associated 
with HIV seropositivity, the approval was on the 
agreement that patient anonymity must be 
maintained, good laboratory practice/quality control 
be ensured, and that every finding would be treated 
with utmost confidentiality and for the purpose of 
this research only. Administration of the herbal 
concoction was carefully carried out strictly on 
consenting participants who were already aware of 
the local names and uses of the herbs tested  (there 
was therefore assurance of safety of the herbs 
before administration). This study was therefore 
carried out in compliance with the international 
guidelines for human experimentation in clinical 
research according to the Declaration of Helsinki 
(World Medical Association and Council for 
International Organizations of Medical Sciences 
(CIOMS). 
 
Study end points:  In general, treatment efficacy 
was defined as an increase of the CD4 cell count by 
at least 50% of the baseline value. AIDS was 
defined as clinical stage C of the 1993 classification 
system for HIV infection (CDC, 1993). 
 
Results and Discussion 
 
Prevalence studies 
Co-infectivity with HIV, Malaria and typhoid were 
apparent in the study.  Out of the 600 persons 
screened for the triple infections, HIV, Malaria and 
Typhoid, 286 (47%), were infected with HIV, 452 
(75%) with malaria, and 401 (66%) with typhoid). 
The uninfected persons were 54 (9%).  Co-
infectivity was therefore observed, an individual was 
dually infected with either of the triple infections, 
indicating a case of dual or multiple infectivity  in the 




Fig. 1: Paradigm of Malaria and Typhoid co-
infection among HIV infected persons 
 
The paradigm of infection is represented below: 
 
Malaria and typhoid co-infection In HIV 
No. screened    600 
No positive for HIV  286  
No positive for typhoid   401  
No positive for malaria  452 
Un-infected   54 
 
Prevalence of HIV Infection: 
Profile  of HIV infected persons in the 
population : preponderance of infection: A total 
of 286 HIV infected persons were observed, 106 
males (37%), and 180 females (62.9%), indicating a 
preponderance of female to male HIV infectivity 
(OR= 4.226, 95% CI 3.00-5.945, P > 0.0001), with 
those within 26-35years in higher proportion, 
followed by those in the 36-45years (n=72), 16-25 
years (n=40), 46-55 years (n=36) and >15years 




Fig. 2: Sex prevalence of HIV infection in the study 
population 
 
Table1: HIV positive cases: age and sex distribution  
(n= 286) 
 
Age Range Male Female Total 
<15 10 5 15 
16–25 12 28 40 
26–35 30 69 99 
36–45 29 43 72 
46–55 15 21 36 
>56 10 14 24 
Total 106 180 286 
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Fig. 2 (alternative): Age and Sex prevalence of HIV 




Preponderance of malaria infection 
In consideration of the pattern of malaria infection in 
the studied population (n = 452), males (77.0%) had 
higher malaria infection prevalence than females 
(73.3%) although no significant difference (P > 
0.05) was found in the prevalence of malaria 
infection. Malaria infection was most prevalent 
among those 26-35 years (n=125).  Next in 
prevalence were those in the age group16-25years. 
The least in the infectivity profile was the >56 age 
group (n=30) (Fig. 3; Table 2).  
 
Table 2:  Malaria positive cases: Age and sex 
distribution (n= 452) 
Age Range Male Female Total 
<15 52 34 86 
16–25 51 46 97 
26–35 76 49 125 
36–45 33 28 61 
46–55 23 30 53 
>56 19 11 30 
Total 254 198 452 
 
 
Fig. 3: profile of age and sex distribution of malaria 
positive cases 
 
Profile of typhoid fever infection  
Typhoid fever was more in females than in males 
(71.5% vs. 63.5%, OR=1.470, 95% CI= 1.04-2.08, 
P < 0.05). A preponderance of the infection was 
observed among the 16-25 age group (n=112). 
Next in the range of infectivity were those between 
the ages 26-35 (n= 94), 36-45 (n=71), 46-55 (n=62) 
and lastly, < 15 (n=21) (Figur 4; Table 3). 
 
Table 3: Typhoid positive cases: Age and sex 
distribution  (n= 401) 
Age Range Male Female Total 
<15 13 8 21 
16–25 64 48 112 
26–35 44 50 94 
36–45 32 39 71 
46–55 37 35 62 
>56 18 13 31 




Fig. 4: Age and Sex Distribution of Typhoid Positive 
Cases 
 
Paradigm of age and sex malaria and typhoid 
co-infectivity among HIV infected persons 
Investigation of the paradigm of sex distribution of  
the multiple infections in the population indicated as 
follows: out of the 286 (47%) HIV infected persons, 
121 were males, while 165 were females in the ratio 
of ---; 452 had malaria parasitemia: 219 , males, 
233 females (ratio: ---); 401 were had typhoid fever 
infection; 202, males, and 199 females (ratio ---) 
(Fig. 5; Table 4). 
 
Table 4: Sex distribution of the multiple infections 




No. Positive Positive HIV 
Male Female 
Positive HIV 286 121 165 
Positive malaria 452 219 233 











Fig. 5: Pattern of gender and age occurrence of 
single and multiple co-infectivity with malaria, 
typhoid  and HIV  (n = 600) 
 
Pattern of single and Multiple Infectivity of the 
Triple Infections in the Population: 
HIV:  single and co-infection 
Out of the 286 HIV positive persons, 2 were singly 
infected, 148 had dual HIV and malaria infections 
while 136 had dual HIV and typhoid infections 
 
Malaria: single and co-infection 
Of the 452 malaria positives cases, 42 had single or 
mono- malaria infection, 148 were dually infected 
with both malaria and HIV, while 262 had dual 
malaria and typhoid infections 
 
Typhoid: single and co-infection 
From a total of 401 typhoid cases, 3 had mono or 
single infection with typhoid, 136 had dual HIV and 
typhoid, while 262 had both typhoid and malaria 
(Table 5; Fig. 6) 
 




Table 7: Baseline mean cd4 lymphocyte count of singly and multiply infected 
 
CD4 Range No of subjects CD4 WBC Lymph PCV 
0–100  39 101+24 7.22 ± 0.9 55.71 ± 22 42.11+2.3 
101–200 182 409 ± 28 10.13 ± 0.9 71.20 ± 20 56.20 ± 2.2 
201–300 121 514 ± 21 15.01 ± 4.1 84.56  ± 81 69.18 ± 3.0 
301–400 105 581 ± 22 16.50 ± 2.0 78.35 ± 43 62.20 ± 1.5 
401–500 46 699 ± 31 18.35 ± 4.2 61.88 ± 33 58.13 ± 51 
501–600 29 714 ± 26 9.55 ± 1.6 66.42 ± 22 55.46 ± 2.1 
601–700 14 802 ± 33 9.01 ± 8.1 55.11 ±16 50.10 ± 2.2 
701–800 6 919 ± 44 10.23 ± 2.0 40.21 ± 26 52.0 ± 3.9 
>800 4 2194 ±65 9.66 ±  4.7 33.19 ± 20 64.12 ±1.1 




Fig. 6: Paradigm of multiple infection with typhoid 
and malaria in HIV infection 
 
Investigation of  haematological parameters: 
The baseline haematological parameters: CD4 
count, total white blood count and differential 
(lymphocyte count), and red blood cell count 
(measured as Packed cell volume- PCV) of the 
triply infected participants in their different CD4 
categories, and the pattern of the gender 
distribution are elucidated in Tables 6 and 7. The 
highest number of triply infected persons (n= 121) 
were within the CD4 range of 201-300.  Average 
counts of other hematologic parameters were: 
514+21 for CD4 cell count; 15.01 ± 4.1 for WBC; 
84.56 ± 81 for lymphocyte count, and 69.18± 3.0 for 
red blood cell (PCV). This was followed by those 
within the 101-200 CD4 category (n=182), with  
average CD4 cell count of 409 ± 28; WBC of 10.13 
± 0.9;  lymphocyte count of 71.20 ± 20 and PCV of 
56.20 ± 2.2.  The least in the category were those in 
the >800 CD4 range (n= 4), with average CD4 
count of 2194 ±65; WBC of 9.66 ± 4.7; lymphocyte 
count of 33.19 ± 20 and PCV of 64.12 ±1.1, 
respectively. On the gender level, out of the 546 
triply infected persons observed, 232 were males, 









Male Female Total 
0–100  101± 31 11 21 39 
101–200 409 ± 28 43 56 182 
201–300 514 ± 21 72 93 121 
301–400 581 ± 22 36 47 105 
401–500 2194 ±65 27 35 46 
501–600 714 ± 26 21 29 29 
601–700 802 ± 33 14 16 14 
701–800 919 ± 44 6 12 6 
>800 2194 ±65 2 5 4 
Total  232 314 546 
 
Antiretroviral therapy and herbal concoctions 

















2 42 3 148 136 262 546 54 
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The effect of antiretroviral therapy using 
conventional ART, and herbal concoction on the 
CD4 counts of the 50 triply infected volunteers (with 
baseline CD4 counts below 200cells/µl) following 
one monthly intervals of treatment is here 
presented. Administered ART included:- AZT: 
Zidovudine, 300mg/12hours; 3TC: Lamivudine, 
150mg/12hours; NVP: Nevirapine, 200mg/day; 
EFV: Efavirenz, 600mg/day; d4T: Stavudine, 
40mg/12hours; ddI: Didanosine, 400mg/day; TDF: 
Tenofovir, 300mg/ day. The volunteers were then 
followed up (at one monthly interval between each 
treatment) with   herbal cocktail: Alstonei boonei 
concoction for malaria, and concoctions of P. nitida, 
Cleistropholis patens (Benth) and Occimum 
gratissimum, in equal proportions for typhoid fever.   
 The results of the CD4 cell counts, before 
and after the treatment are here elucidated. 
Available results indicated that the 50 volunteer 
patients had mean CD4 count of 118.60+60.17 
cells/µl before treatment.  However, following 
administration of the antiretroviral and the herbal 
concoctions, a total of 39 patients responded 
positively to the treatment, with significantly 
increased mean CD4 count of 202.31+86.72 
cells/µl. Using the different antiretroviral drugs and 
effectors, it was observed that the different drug 
regimen significantly boosted (P < 0.05) the CD4 
count at the end of treatment (Tables 8, Fig. 7). 
Generally, a significant statistical difference (P < 
0.05) was found between the CD4 count of 
volunteers had positive and negative response to 
drugs after treatment (220.85+85.13 vs. 
122.00+28.67 cells/µl, P < 0.05). Nevertheless, no 
significant difference (P > 0.05) was found in the 
CD4 cell count of male and female volunteers 
before (110.25 +55.51 vs. 122.78 +62.81 cells/µl) 
and after (177.69+82.64 vs. 214.63+87.34 cells/µl) 
treatment.  
 
Table 8: The CD4 counts of HIV patients before and 






count before ART 
Final CD4 count 
after ART 
Overall drug effect  118.60+60.17 202.31+86.72* 
AZT, 3TC, NVP + 
Effector 
118.43+55.21 183.29+70.86* 
D4T, 3TC, NVP + 
Effector 
112.90 + 58.67 190.80 +103.51* 
DDL, TDF, LPV + 
Effector 
123.70 + 60.98 201.90 + 64.06* 
D4T, 3TC, EFV + 
Effector 
149.60 + 65.99 267.00 + 52.86* 
D4T, AZT, NVP + 
Effector 
87.17+ 28.72 180.50+41.95* 
AZT, 3TC, EFV + 
Effector 
132.67+ 78.24 266.67 +56.08* 
*significant difference (P > 0.05)  
Similarly, levels of TWBC, HB and PCV were 
significantly improved (P < 0.05) following the 
treatment (Table 9, Fig.s 7 and 8). Furthermore, 
comparing the TWBC, HB and PCV of volunteers 
who had negative and positive response after 
treatment, significant increase (P < 0.05) was only 
observed in the HB of those who responded 
positively to treatment (Table 10). 
 
Table 9: Haematological Tests of HIV Positive 





After therapy  
TWBC 4.57+ 1.71 6.14+1.34* 
HB 10.51+2.17 30.49+16.65* 
PCV 31.97+5.95 41.95+11.97* 
*significant difference (P > 0.05)  
 
Table 10: Haematological Tests of HIV Positive 









HB 15.57+8.97 32.53+16.47* 
PCV 37.57+13.06 42.56+11.34
ns 






































Fig. 8:  Profile of  haematological tests
 
In Nigeria and many developing countries, several 
healthcare challenges still exist especially among 
HIV/AIDS infected individuals. The lack of good 
healthcare facilities and modern diagnostic 
equipment, lack of adequate and experienced 
manpower, poor disease surveillance strategies, 
stigmatization and other socioeconomic factors are 
some of these challenges. Although very concerted 
efforts have been made in the last decade to reduce 
the ravaging effect of HIV/AIDS pandemic all over 
the world, the impact of HIV/AIDS is still alarming 
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especially in many developing countries including 
Nigeria. Opportunistic infections and other kinds of 
infections such as malaria and typhoid are thought 
to complicate HIV/AIDS infections in sub-Saharan 
Africa and have recently drawn more research 
attention (Chandramohan and Greenwo, 1998).  
This is the motivation for our study. 
It is disturbing to learn that over 80% of 
malaria deaths in the world today are known to 
occur in Africa. On the other hand, typhoid infection 
is also a very well-known healthcare problem in 
Africa. Unfortunately, the true magnitude of typhoid 
infection is difficult to estimate due to the confusion 
arising from the similarity in the clinical picture of 
typhoid and other febrile illnesses. Malaria, typhoid 
and HIV co-infection and the subsequent 
interactions between them may therefore have 
major implications for the treatment, care and 
prevention of these infections especially HIV/AIDS. 
As expected, co-infections with HIV, 
malaria and typhoid fever were observed in the 
study. A very disturbing situation is the finding that a 
total of 47% of the 600 persons screened had 
HIV/AIDS. Of the positive HIV confirmed cases, 106 
(37%) were males while 180(62.9%) were females. 
More females were significantly more infected with 
HIV than males (P< 0.05),with those in the age 
bracket of 26-35 years being the most affected, 
followed closely by those in the age range of 36-45 
years. This is consistent with previous findings. The 
reason for the higher prevalence in female 
compared to male population is not known.  The 
unfortunate scenario is that the bulk of those 
infected with HIV are individuals within the labour 
force (26-45 years). This portends a very great 
danger to the economy of Nigeria and other 
countries with similar situations since any 
developed or developing country depends largely 
on its labour force to grow the economy.  
The sex and age distribution of malaria 
and typhoid positive patients appear to follow the 
same trend: infection was more in males than 
females although not significantly different (P>0.05) 
while incidence of both infections increased with 
decreasing age for malaria and typhoid infections 
respectively. It is difficult to predict the reason why 
the male population had more incidences of both 
infections. It might however be due to geographical 
factors. A possibility also might be due to the fact 
that the male population in Uzo-Uwani are 
predominantly farmers who spend most of their time 
in farms located in remote malaria and typhoid 
endemic villages where they are more disposed to 
these infections. 
The high incidence of both infections in the 
younger age groups is consistent with the findings 
from previous investigators (Agwu et al., 2009; 
Tatfeng et al., 2007). Conversely, when malaria, 
typhoid and HIV cases investigated in the study 
were pulled together, the number of cases in the 
female population was higher than what was 
observed in the male population (597:542). Of this 
number, 75 and 66% respectively have malaria and 
typhoid fever, indicating a case of dual or multiple 
infections among those screened. This observation 
brings to bear, once more, the risk of malaria and 
typhoid fever infections among HIV/AIDS patients 
living in malaria/typhoid endemic areas. Previous 
studies in both Ekpoma and Benin city in Edo state, 
Nigeria reported similar findings with respect to 
malaria among HIV/AIDS patients. Whereas the 
prevalence of malaria in HIV/AIDS was 74.6% in 
Ekpoma, that in Benin was 88.8% ( Agwu et al., 
2009; Tatfeng et al., 2007).  Both values therefore 
compare closely with 75% found in our study. There 
are reports which indicate that clinical presentation 
of malaria does not vary according to HIV status. 
This report also argued that it is difficult to 
distinguish the clinical presentation of malaria from 
other causes of febrile illness in persons with HIV 
infection ( Mbuh et al., 2004). 
Our findings are not in agreement with the 
former statement. Nevertheless, another group had 
previously reported that there are indications that 
malaria and typhoid infections might have adverse 
effects in HIV positive individuals by impairing 
cytotoxic T cell function, stimulating T cell turnover 
and damaging the placenta in a manner that will aid 
HIV transmission in the uterus (Chandramohan et 
al., 1998 )  In a recent review article, (Gordon, 
2008) showed that single-center studies previously 
carried out in Africa and Asia failed to demonstrate 
any specific interaction of HIV with typhoid fever 
(Gordon, 2008) In fact,  Crump and co-workers 
(Crump et al., 2011) carried out a study in Tanzania 
where the high incidence of typhoid in an HIV-
prevalent area allowed the authors to document an 
apparent protective effect of HIV against 
presentation with typhoid fever. They clearly 
showed that HIV was protective against S. typhi 
bloodstream infection in their febrile adult cohort, in 
contrast to the strong positive association that has 
repeatedly been observed between HIV and 
invasive typhoid and non-typhoid Salmonella 
disease in this and other studies (Gordon et al., 
2008) In a different study involving the same author 
(Gordon, 2002) it was demonstrated that this 
apparent negative association could be due to a 
lack of cell-mediated immune response to S. typhi 
in HIV-infected individuals, such that although 
infected, those patients  do not show symptoms of 
fever or other inflammatory features. They rather, 
have intracellular, quiescent, sub-clinical disease. 
This looked like an attractive hypothesis. However, 
if this was the case, then the expectation might be 
that the availability and high uptake of free ART in 
Africa might result in clinically obvious S. typhi-
related disease manifesting during immune 
reconstitution as an IRIS syndrome, but this has not 
been reported in Nigeria or other African ART 
cohorts. This apparently lends credence to our 
finding in this study that there is a likely interaction 
between typhoid fever and HIV infections.  The high 
prevalence of typhoid is not surprising either. Since 
it is transmitted via contaminated food and water, 
infection is high in areas where sanitary condition is 
poor and use of untreated water is common. These 
conditions are peculiar in the environment under 
study. The situation is not helped by the 
development of antibiotic resistant strains of 
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Salmonella typhi, the causative agent of typhoid. 
Moreover, as more Nigerians relocate/migrate to 
urban areas, living in crowded, squalid conditions, 
these new environments may likely lead to a 
different epidemiology for typhoid and malaria to 
thrive. 
Table 5 shows that HIV patients were 
more at risk of acquiring malaria or typhoid. The 
reason is perhaps as a result of the lower immune 
status of the patient. This trend is expected and has 
been reported for other infections associated with 
HIV patients. When pulled together, those who had 
all the three infections were 546 out of the 600 
persons investigated. The finding in our study that 
262 persons screened had co-infection of typhoid 
and malaria emphasizes the severity of these 
infections in Nigeria. Our data agrees with previous 
findings in Zaria, Nigeria by (Mbu et al., 2004) . 
They also reported that there is a high rate of 
malaria and typhoid co-infection with the widal test. 
This is because there are certain limitations 
associated with the use of widal test as a diagnostic 
tool in patients with malaria. This is one of the 
limitations of our study. Salmonella typhi antibodies 
cross-react with malaria and non-typhoid 
Salmonella antigens, meaning that the use of widal 
test as a diagnostic procedure in patents with 
malaria might lead to misleading results. (Koelman, 
1992) also reported cross-reactions due to latent 
and post-infectious diseases such as chronic 
hepatitis, rheumatoid arthritis, amoebiasis, 
tuberculosis and pneumonia (Koeleman, 1992). 
Mbu and co- workers (2003) also observed that 
there are more typhoid fever cases in areas with 
drug resistant malaria and concluded that a cross 
reaction between malaria parasites and Salmonella 
antigens may lead to false positive widal 
agglutination test. By using the aforementioned 
method, we cannot therefore do a 100% accurate 
assessment that these patients are suffering from a 
true co-infection of malaria and typhoid. We chose 
to use the widal test since it is the most widely used 
procedure in the diagnosis of typhoid fever in 
Nigeria. It is known generally that blood culture is 
usually the gold standard for the diagnosis of 
typhoid fever. Unfortunately, it is not usually 
requested for by many physicians because of its 
cost and the length of time (≥ 3 days) required 
before results are obtained. In future studies, we 
plan to compare Salmonella isolation data from 
blood samples of those positive for widal tests. 
Changes in haematological and biochemical 
parameters have been reported in malaria (Bidaki, 
2003) and typhoid infections (Mishra, 2003).
 
These 
parameters are useful in the diagnosis of many 
diseases since it helps to detect complications 
associated with many disease conditions. 
Ultimately, they are used by clinicians to care for 
the patient and prevent death which may result due 
to such complications. Our results indicate that the 
co-infection of malaria, typhoid and HIV caused 
some alterations in the haematological parameters 
of the patients screened in this study. Although their 
study did not screen for HIV in the samples tested, 
(Kayode et al., 2011) also made similar 
observations while investigating changes in some 
haematological indices in patients co-infected with 
malaria and typhoid fever in Ota, Ogun State 
Nigeria (Kayode et al., 2011). The packed cell 
volume generally decreased in those that were co-
infected. This is expected perhaps due to the 
breakdown of red blood cells that are common in 
malaria and typhoid patients, thus suggesting that 
anemia might be involved. Similar observations 
were made by other investigators in both malaria ( 
Ogbodo et al., 2010; Goselle et al., 2009) and 
typhoid fever patients ( Dangana et al., 2010) . We 
also observed a general increase in white blood cell 
and lymphocyte counts among those with triple 
infections compared to normal counts in healthy 
individuals. The increase in white blood cell counts 
in these subjects might be due to the invasion of the 
body by the pathogens and consequential secretion 
of leukocytes to fight against the invading 
pathogens particularly at onset of the infection. 
(Kayode et al., 2011) and (Sumbele et al., 2010) 
both separately reported increases in leukocytes 
among malaria patients in Nigeria and Cameroon 
respectively (Kayode et al., 2011; Sumbele et al., 
2010). However, there were both increased and 
decreased leukocyte counts in typhoid fever 
patients screened in the United Arab Emirates (Ali 
et al., 2009). 
Of note however is the observation that a 
significantly higher number of patients (89.4%) with 
triple infections screened in the study had CD4 
counts in the range of 0-400 compared to only 
10.6% with CD4 counts of 400 and above. This 
suggests that either these HIV patients are not 
responding well to ART, are not using ART (naïve) 
or are not responding well as a result of the triple 
infections. This finding motivated us to administer 
the concoctions used by these villagers and 
compare their outcomes with a panel of ARTs 
currently in use in the locality.  
The effect of antiretroviral therapy using 
conventional ART, and herbal concoction on the 
CD4 counts of the 50 triply infected volunteers (with 
baseline CD4 counts below 200cells/µl)  following 
one monthly intervals of treatment showed that all 
50 volunteer patients had mean CD4 count of 
118.60+60.17 cells/µl before treatment.  However, 
following administration of the antiretroviral and the 
herbal concoctions, a total of 39 patients responded 
positively to the treatment, with significantly 
increased mean CD4 count of 202.31+86.72 
cells/µl. Using the different antiretroviral drugs and 
effectors, it was observed that the different drug 
regimen significantly boosted (P < 0.05) the CD4 
count at the end of treatment. This is good news. A 
likely reason for this observation might be due to 
the efficacy of the concoctions which effectively 
controlled malaria and typhoid infections and 
consequently boosted the CD4 counts of the 39 HIV 
patients. This is not unusual though since it is 
generally known that controlling opportunistic and 
other infections in HIV patients usually lead to 
improvements in CD4 counts. Our findings 
generally justify why the herbs Alstonei boonei, P. 
nitida, Cleistropholis patens and Occimum 
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gratissimum are used in folkoric medicine to treat 
malaria and typhoid in southeastern Nigeria. This is 
also supported by the information in literature.  
Overall, this study has shown that malaria 
and typhoid co-infections are highly common 
among HIV/AIDS patients in Uzo-Uwani local 
government area of Enugu State, Southeast 
Nigeria. Mbu et al noted that this could significantly 
increase the risk of HIV transmission through blood 
transfusion (Mbuh et al., 2004). Many factors seem 
to predispose HIV/AIDS patients to malaria and 
typhoid infections in the area under study: poor 
sanitation and health facilities, lack of good disease 
surveillance strategies, occupation and poor control 
and prevention of malaria among others. Some of 
the herbal concoctions in the localities might be 
useful in the management of those with triple 
infections. Future research ought to focus more 
attention on these herbal remedies and their 
possible use in managing malaria and typhoid 
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